Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Man Killed in Train Crash on Montecito Street


Victim Hit by Amtrak Train in Fatal Santa Barbara Accident

Santa Barbara, CA (March 21, 2020) – A man was killed in a train crash in Santa Barbara. The fatal accident occurred on the morning of March 21 on Montecito Street.

An Amtrak train was heading south when it hit a pedestrian. The cause of the crash is unknown. The victim, a man, died at the accident scene. The train was delayed as authorities investigated.

Our heartfelt condolences go out to the friends and loved ones of the victim. 

#Santa Barbara

#93103


April 15, 2020

1 Injured in Crash on Interstate 10 Near Citrus Avenue

2 Vehicles Collide in Hit and Run Accident in Fontana...


November 19, 2019

7 Injured in Crash on Dehesa Road

Bus, Car Collide in Head-on Crest Accident...


November 15, 2019

Crash at Interstate 880 and High Street Causes Minor Injuries

3 Vehicles Involved in Oakland Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.